Ligand Pharmaceuticals Statistics
Total Valuation
LGND has a market cap or net worth of $5.82 billion. The enterprise value is $5.59 billion.
| Market Cap | 5.82B |
| Enterprise Value | 5.59B |
Important Dates
The last earnings date was Thursday, August 6, 2026, before market open.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
LGND has 19.94 million shares outstanding. The number of shares has increased by 12.96% in one year.
| Current Share Class | 19.94M |
| Shares Outstanding | 19.94M |
| Shares Change (YoY) | +12.96% |
| Shares Change (QoQ) | +9.83% |
| Owned by Insiders (%) | 2.26% |
| Owned by Institutions (%) | 115.88% |
| Float | 19.48M |
Valuation Ratios
The trailing PE ratio is 31.74 and the forward PE ratio is 42.33. LGND's PEG ratio is 1.74.
| PE Ratio | 31.74 |
| Forward PE | 42.33 |
| PS Ratio | 20.02 |
| Forward PS | 17.28 |
| PB Ratio | 6.01 |
| P/TBV Ratio | 8.86 |
| P/FCF Ratio | 44.25 |
| P/OCF Ratio | 44.16 |
| PEG Ratio | 1.74 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 42.03, with an EV/FCF ratio of 42.53.
| EV / Earnings | 28.35 |
| EV / Sales | 19.24 |
| EV / EBITDA | 42.03 |
| EV / EBIT | 55.85 |
| EV / FCF | 42.53 |
Financial Position
The company has a current ratio of 31.18, with a Debt / Equity ratio of 1.17.
| Current Ratio | 31.18 |
| Quick Ratio | 30.83 |
| Debt / Equity | 1.17 |
| Debt / EBITDA | 8.46 |
| Debt / FCF | 8.61 |
| Interest Coverage | 16.17 |
Financial Efficiency
Return on equity (ROE) is 21.96% and return on invested capital (ROIC) is 11.76%.
| Return on Equity (ROE) | 21.96% |
| Return on Assets (ROA) | 3.99% |
| Return on Invested Capital (ROIC) | 11.76% |
| Return on Capital Employed (ROCE) | 4.68% |
| Weighted Average Cost of Capital (WACC) | 8.16% |
| Revenue Per Employee | $6.18M |
| Profits Per Employee | $4.20M |
| Employee Count | 47 |
| Asset Turnover | 0.19 |
| Inventory Turnover | 4.24 |
Taxes
In the past 12 months, LGND has paid $40.74 million in taxes.
| Income Tax | 40.74M |
| Effective Tax Rate | 17.12% |
Stock Price Statistics
The stock price has increased by +93.12% in the last 52 weeks. The beta is 0.98, so LGND's price volatility has been similar to the market average.
| Beta (5Y) | 0.98 |
| 52-Week Price Change | +93.12% |
| 50-Day Moving Average | 290.48 |
| 200-Day Moving Average | 226.27 |
| Relative Strength Index (RSI) | 48.43 |
| Average Volume (20 Days) | 263,507 |
Short Selling Information
The latest short interest is 2.17 million, so 10.88% of the outstanding shares have been sold short.
| Short Interest | 2.17M |
| Short Previous Month | 1.92M |
| Short % of Shares Out | 10.88% |
| Short % of Float | 11.14% |
| Short Ratio (days to cover) | 6.00 |
Income Statement
In the last 12 months, LGND had revenue of $290.54 million and earned $197.22 million in profits. Earnings per share was $9.19.
| Revenue | 290.54M |
| Gross Profit | 235.92M |
| Operating Income | 100.10M |
| Pretax Income | 237.96M |
| Net Income | 197.22M |
| EBITDA | 133.01M |
| EBIT | 100.10M |
| Earnings Per Share (EPS) | $9.19 |
Balance Sheet
The company has $1.36 billion in cash and $1.13 billion in debt, with a net cash position of $226.31 million or $11.35 per share.
| Cash & Cash Equivalents | 1.36B |
| Total Debt | 1.13B |
| Net Cash | 226.31M |
| Net Cash Per Share | $11.35 |
| Equity (Book Value) | 967.52M |
| Book Value Per Share | 48.57 |
| Working Capital | 1.41B |
Cash Flow
In the last 12 months, operating cash flow was $131.71 million and capital expenditures -$278,000, giving a free cash flow of $131.44 million.
| Operating Cash Flow | 131.71M |
| Capital Expenditures | -278,000 |
| Depreciation & Amortization | 32.91M |
| Net Borrowing | 850.93M |
| Free Cash Flow | 131.44M |
| FCF Per Share | $6.59 |
Margins
Gross margin is 81.20%, with operating and profit margins of 34.45% and 67.88%.
| Gross Margin | 81.20% |
| Operating Margin | 34.45% |
| Pretax Margin | 81.90% |
| Profit Margin | 67.88% |
| EBITDA Margin | 45.78% |
| EBIT Margin | 34.45% |
| FCF Margin | 45.24% |
Dividends & Yields
LGND does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -12.96% |
| Shareholder Yield | -12.96% |
| Earnings Yield | 3.39% |
| FCF Yield | 2.26% |
Analyst Forecast
The average price target for LGND is $342.82, which is 17.50% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $342.82 |
| Price Target Difference | 17.50% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (3Y) | 17.97% |
| EPS Growth Forecast (3Y) | 20.53% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on November 19, 2010. It was a reverse split with a ratio of 1:6.
| Last Split Date | Nov 19, 2010 |
| Split Type | Reverse |
| Split Ratio | 1:6 |
Scores
LGND has an Altman Z-Score of 3.31 and a Piotroski F-Score of 5.
| Altman Z-Score | 3.31 |
| Piotroski F-Score | 5 |